IC
MNTA

Intersect Capital’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Intersect Capital’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-10
Closed – – 402
2015
Q1 		$0 Hold
10
– – ﹤0.01% 494
2014
Q4 		$0 Buy
+10
New +$114 ﹤0.01% 450

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Intersect Capital's MNTA Position: Q2 2015 in Review

Intersect Capital sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2015, closing a stake of 10 shares.

Intersect Capital first reported a position in MNTA in Q4 2014 and held it in 2 quarters. The position peaked at $0 in Q1 2015. 162 funds tracked by Wall St. Rank hold MNTA as of Q2 2015.

  • Intersect Capital reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • Intersect Capital sold 10 Momenta Pharmaceuticals, Inc. shares in Q2 2015.
  • Intersect Capital first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2014 and held it in 2 quarters.
  • Intersect Capital's Momenta Pharmaceuticals, Inc. position peaked at $0 in Q1 2015.
  • 162 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2015.

Based on Intersect Capital's 13F filing for Q2 2015, filed 3 Aug 2015.